GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioCryst Pharmaceuticals Inc (MEX:BCRX) » Definitions » Common Stock

BioCryst Pharmaceuticals (MEX:BCRX) Common Stock : MXN43 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is BioCryst Pharmaceuticals Common Stock?

BioCryst Pharmaceuticals's quarterly common stock increased from Jun. 2024 (MXN38 Mil) to Sep. 2024 (MXN41 Mil) and increased from Sep. 2024 (MXN41 Mil) to Dec. 2024 (MXN43 Mil).

BioCryst Pharmaceuticals's annual common stock declined from Dec. 2022 (MXN37 Mil) to Dec. 2023 (MXN35 Mil) but then increased from Dec. 2023 (MXN35 Mil) to Dec. 2024 (MXN43 Mil).


BioCryst Pharmaceuticals Common Stock Historical Data

The historical data trend for BioCryst Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCryst Pharmaceuticals Common Stock Chart

BioCryst Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.19 37.81 36.63 34.93 43.48

BioCryst Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.93 34.24 37.85 40.78 43.48

BioCryst Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


BioCryst Pharmaceuticals Business Description

Traded in Other Exchanges
Address
4505 Emperor Boulevard, Suite 200, Durham, NC, USA, 27703
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.